On the other hand, it is known that inhibiting the EAG1 potassium channel suppresses the proliferation of breast cancer cells, arrests cell cycle progression in the G1 phase [37,38], and decreases cyclin D1 expression [39]. This evidence concerns the gene CCND1 and breast carcinoma.